Lupin Limited has launches Tavaborole Topical Solution, 5% in US
Indian pharma company Lupin Limited has launched Tavaborole Topical Solution, 5% following regulatory approval from the US Food and Drug Administration (FDA). Tavaborole Topical Solution, 5%, is a generic version of Kerydin Topical Solution, 5%, owned by Anacor Pharmaceuticals. It is an oxaborole antifungal, which has been approved by the FDA for the topical treatment […]